Views & Analysis Hung parliament: who will pharma negotiate with on new PPRS? Who could influence the makeup of the new PPRS?
Views & Analysis New UK law to control generic drug prices - implications for... The aims and implications of the Health Service Medical Supplies (Costs) Act 2017.
Views & Analysis Budget impact and cost effectiveness: Can the UK learn from ... Leela Barham examines the approach of the Institute for Clinical and Economic Review.
News "I'm going to bring down drug prices" - Trump President-elect takes swipe at pharma after Time "Person of the Year" accolade.
News Trump elected president: what now for pharma? Trump has called for Medicare to negotiate drug prices.
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
